Abstract
A series of 1-benzyl-4,5,6-trimethoxyindoles was designed and prepared as a novel class of potent antimitotic agents acting through the colchicine binding site of tubulin. Compounds 10 and 11 showed excellent antiproliferative activity with mean IC50 values of 26 and 27 n M, respectively, in a diverse set of human cancer lines from different organs, including a MDR+ line. They also displayed substantial antitubulin efficacy with IC50 values of 3.5 and 2.6 μM, respectively, representing an improvement over colchicine (IG50=4.3μM).
Original language | English |
---|---|
Pages (from-to) | 588-593 |
Number of pages | 6 |
Journal | ChemMedChem |
Volume | 4 |
Issue number | 4 |
DOIs | |
Publication status | Published - Apr 17 2009 |
Keywords
- Antitumor agents
- Drug design
- Inhibitors
- Structure-activity relationships
- Tubulin polymerization
ASJC Scopus subject areas
- Drug Discovery
- General Pharmacology, Toxicology and Pharmaceutics
- Molecular Medicine
- Biochemistry
- Pharmacology
- Organic Chemistry